Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Minority Interest (2020 - 2025)

Maravai Lifesciences Holdings has reported Minority Interest over the past 6 years, most recently at $160.3 million for Q4 2025.

  • Quarterly results put Minority Interest at $160.3 million for Q4 2025, down 36.36% from a year ago — trailing twelve months through Dec 2025 was $160.3 million (down 36.36% YoY), and the annual figure for FY2025 was $160.3 million, down 36.36%.
  • Minority Interest for Q4 2025 was $160.3 million at Maravai Lifesciences Holdings, down from $186.4 million in the prior quarter.
  • Over the last five years, Minority Interest for MRVI hit a ceiling of $379.1 million in Q1 2023 and a floor of $99.7 million in Q1 2021.
  • Median Minority Interest over the past 5 years was $269.8 million (2022), compared with a mean of $270.8 million.
  • Biggest five-year swings in Minority Interest: skyrocketed 247.04% in 2021 and later tumbled 40.16% in 2025.
  • Maravai Lifesciences Holdings' Minority Interest stood at $229.9 million in 2021, then skyrocketed by 56.63% to $360.0 million in 2022, then rose by 3.64% to $373.1 million in 2023, then plummeted by 32.49% to $251.9 million in 2024, then tumbled by 36.36% to $160.3 million in 2025.
  • The last three reported values for Minority Interest were $160.3 million (Q4 2025), $186.4 million (Q3 2025), and $202.1 million (Q2 2025) per Business Quant data.